ImmunityBio, Inc. IBRX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s common stock, shares issued (in shares)?
- ImmunityBio, Inc. (IBRX) reported common stock, shares issued (in shares) of $1.05B in Q1 2026.
- How has ImmunityBio, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- ImmunityBio, Inc.'s common stock, shares issued (in shares) increased by 22.7% year-over-year, from $853.56M to $1.05B.
- What is the long-term trend for ImmunityBio, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock, shares issued (in shares) has grown at a 21.5% compound annual growth rate (CAGR), from $382.24M to $1.01B.